SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marjorie McMillan, Keith S. Rotenberg, Kevin Vora, Arnold B. Sterman, Lionel Thevathasan, Michael F. Ryan, Munish Mehra, Walter Sandulli, Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project, Drugs in R&D, 2016, 16, 1, 53

    CrossRef

  2. 2
    Jan Peter Yska, Douwe H. van der Meer, Albert R. Dreijer, Willeke Eilander, Jan A. Apers, Marloes Emous, Erik R. E. Totté, Bob Wilffert, Eric N. van Roon, Influence of bariatric surgery on the use of medication, European Journal of Clinical Pharmacology, 2016, 72, 2, 203

    CrossRef

  3. 3
    Jacques Orgiazzi, Obese Patients with Hypothyroidism May Require Lower Doses of Levothyroxine After Bariatric Surgery, Clinical Thyroidology, 2016, 28, 4, 114

    CrossRef

  4. 4
    Célia Lloret-Linares, Lorry Hachon, Xavier Declèves, Pharmacologie des antalgiques chez le sujet obèse, Revue du Rhumatisme Monographies, 2016, 83, 1, 59

    CrossRef

  5. 5
    Poupak Fallahi, Silvia Martina Ferrari, Ilaria Ruffilli, Alessando Antonelli, Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series, BMC Gastroenterology, 2016, 16, 1

    CrossRef

  6. 6
    Lieke Mitrov-Winkelmolen, Marie-Christine W. van Buul-Gast, Dingeman J. Swank, Hans W P M Overdiek, Ron H. N. van Schaik, Daan J. Touw, The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study, Obesity Surgery, 2016,

    CrossRef

  7. 7
    Wilmar M. Wiersinga, Endocrinology: Adult and Pediatric, 2016,

    CrossRef

  8. 8
    Matthew Zuckerman, Howard A Greller, Kavita M Babu, A Review of the Toxicologic Implications of Obesity, Journal of Medical Toxicology, 2015, 11, 3, 342

    CrossRef

  9. 9
    C. Lloret-Linares, L. Hachon, Adaptation posologique chez le sujet obèse, Réanimation, 2015, 24, 4, 367

    CrossRef

  10. 10
    Ina Gesquiere, Patrick Augustijns, Matthias Lannoo, Christophe Matthys, Bart Van der Schueren, Veerle Foulon, Barriers in the Approach of Obese Patients Undergoing Bariatric Surgery in Flemish Hospitals, Obesity Surgery, 2015, 25, 11, 2153

    CrossRef

  11. 11
    Marcus May, Stefan Engeli, Besonderheiten der Pharmakotherapie adipöser Patienten, CardioVasc, 2015, 15, 3, 45

    CrossRef

  12. 12
    B. L. da S. Guedes, M. C. Montanha, J. J. V. Teixeira, A. Diniz, S. R. B. Silva, I. Previdelli, D. Nasser, S. S. Yamada, E. Kimura, Clinicians' prescribing practices for bariatric surgery patients: is there an issue?, Journal of Clinical Pharmacy and Therapeutics, 2015, 40, 1
  13. 13
    Mark A. Marzinke, Athena K. Petrides, Kimberley Steele, Michael A. Schweitzer, Thomas H. Magnuson, Shauna P. Reinblatt, Janelle W. Coughlin, William Clarke, Decreased Escitalopram Concentrations Post–Roux-en-Y Gastric Bypass Surgery, Therapeutic Drug Monitoring, 2015, 37, 3, 408

    CrossRef

  14. 14
    Ina Gesquiere, Adam S. Darwich, Bart Van der Schueren, Jan Hoon, Matthias Lannoo, Christophe Matthys, Amin Rostami, Veerle Foulon, Patrick Augustijns, Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations, British Journal of Clinical Pharmacology, 2015, 80, 5
  15. 15
    Poupak Fallahi, Silvia Martina Ferrari, Alessandro Antonelli, Oral l-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study, Endocrine, 2015,

    CrossRef

  16. 16
    Vasanth Kattalai Kailasam, Claricio DeCastro, Claude Macaluso, Anne Kleiman, Postbariatric Surgery Neuropathic Pain (PBSNP): Case Report, Literature Review, and Treatment Options, Pain Medicine, 2015, 16, 2
  17. 17
    Lingtak-Neander Chan, Yvonne S. Lin, Jessica C. Tay-Sontheimer, Dorothy Trawick, Brant K. Oelschlager, David R. Flum, Kristen K. Patton, Danny D. Shen, John R. Horn, Proximal Roux-en-Y Gastric Bypass Alters Drug Absorption Pattern But Not Systemic Exposure of CYP3A4 and P-glycoprotein Substrates, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015, 35, 4
  18. 18
    James L. Roerig, Kristine Steffen, Psychopharmacology and Bariatric Surgery, European Eating Disorders Review, 2015, 23, 6
  19. 19
    Angelos Kyriacou, John McLaughlin, Akheel A. Syed, Thyroid disorders and gastrointestinal and liver dysfunction: A state of the art review, European Journal of Internal Medicine, 2015, 26, 8, 563

    CrossRef

  20. 20
    Hassan Mobayed, Wanis Ibrahim, Maryam Al-Nesf, Delayed clavulanic acid–induced anaphylaxis in a patient undergoing bariatric surgery, Annals of Allergy, Asthma & Immunology, 2014, 113, 3, 324

    CrossRef

  21. 21
    Célia Lloret-Linares, Déborah Hirt, Christophe Bardin, Jean-Luc Bouillot, Jean-Michel Oppert, Christine Poitou, François Chast, Stéphane Mouly, Jean-Michel Scherrmann, Jean-François Bergmann, Xavier Declèves, Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach, Clinical Pharmacokinetics, 2014, 53, 10, 919

    CrossRef

  22. 22
    M. Fried, V. Yumuk, J. M. Oppert, N. Scopinaro, A. Torres, R. Weiner, Y. Yashkov, G. Frühbeck, Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery, Obesity Surgery, 2014, 24, 1, 42

    CrossRef

  23. You have free access to this content23
    Kangwon Song, Michael J. Melroy, Oliver C. Whipple, Optimizing Multimodal Analgesia with Intravenous Acetaminophen and Opioids in Postoperative Bariatric Patients, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014, 34, S1
  24. 24
    B. M. Knoll, Pharmacokinetics of oral isavuconazole in a patient after Roux-en-Y gastric bypass surgery, Journal of Antimicrobial Chemotherapy, 2014, 69, 12, 3441

    CrossRef

  25. You have free access to this content25
    J. Stein, C. Stier, H. Raab, R. Weiner, Review article: the nutritional and pharmacological consequences of obesity surgery, Alimentary Pharmacology & Therapeutics, 2014, 40, 6
  26. 26
    Kathleen Bingham, Raed Hawa, Sanjeev Sockalingam, SSRI Discontinuation Syndrome Following Bariatric Surgery: A Case Report and Focused Literature Review, Psychosomatics, 2014, 55, 6, 692

    CrossRef

  27. 27
    F. Phan, J.-M. Oppert, F. Andreelli, Synthèse des recommandations interdisciplinaires européennes sur la chirurgie bariatrique et métabolique, Médecine des Maladies Métaboliques, 2014, 8, 6, 652

    CrossRef

  28. 28
    Roberto Vita, Poupak Fallahi, Alessandro Antonelli, Salvatore Benvenga, The administration ofl-thyroxine as soft gel capsule or liquid solution, Expert Opinion on Drug Delivery, 2014, 11, 7, 1103

    CrossRef

  29. 29
    Margaret Malone, Nutrition and Bariatric Surgery, 2014,

    CrossRef

  30. 30
    James L. Roerig, Kristine J. Steffen, Cheryl Zimmerman, James E. Mitchell, Ross D. Crosby, Li Cao, A Comparison of Duloxetine Plasma Levels in Postbariatric Surgery Patients Versus Matched Nonsurgical Control Subjects, Journal of Clinical Psychopharmacology, 2013, 33, 4, 479

    CrossRef

  31. 31
    Roberto Vita, Giovanna Saraceno, Francesco Trimarchi, Salvatore Benvenga, A novel formulation of l-thyroxine (l-T4) reduces the problem of l-T4 malabsorption by coffee observed with traditional tablet formulations, Endocrine, 2013, 43, 1, 154

    CrossRef

  32. 32
    Adriane N. Irwin, Kathleen H. McCool, Thomas Delate, Daniel M. Witt, Assessment of Warfarin Dosing Requirements After Bariatric Surgery in Patients Requiring Long-Term Warfarin Therapy, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 11
  33. 33
    Hermann J. Kissler, Utz Settmacher, Bariatric Surgery to Treat Obesity, Seminars in Nephrology, 2013, 33, 1, 75

    CrossRef

  34. 34
    Jeffrey I. Mechanick, Adrienne Youdim, Daniel B. Jones, W. Timothy Garvey, Daniel L. Hurley, M. Molly McMahon, Leslie J. Heinberg, Robert Kushner, Ted D. Adams, Scott Shikora, John B. Dixon, Stacy Brethauer, Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery, Surgery for Obesity and Related Diseases, 2013, 9, 2, 159

    CrossRef

  35. 35
    Jeffrey Mechanick, Adrienne Youdim, Daniel Jones, W. Garvey, Daniel Hurley, M. McMahon, Leslie Heinberg, Robert Kushner, Ted Adams, Scott Shikora, John Dixon, Stacy Brethauer, Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery, Endocrine Practice, 2013, 19, 2, 337

    CrossRef

  36. You have free access to this content36
    Jeffrey I. Mechanick, Adrienne Youdim, Daniel B. Jones, W. Timothy Garvey, Daniel L. Hurley, M. Molly McMahon, Leslie J. Heinberg, Robert Kushner, Ted D. Adams, Scott Shikora, John B. Dixon, Stacy Brethauer, Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*, Obesity, 2013, 21, S1
  37. 37
    Pieter Colin, Lies De Bock, Huybrecht T'jollyn, Koen Boussery, Jan Van Bocxlaer, Development and validation of a fast and uniform approach to quantify β-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography–electrospray-tandem mass spectrometry, Talanta, 2013, 103, 285

    CrossRef

  38. 38
    Jan Peter Yska, Susanne van der Linde, Véronique V. Tapper, Jan A. Apers, Marloes Emous, Erik R. Totté, Bob Wilffert, Eric N. van Roon, Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes, Obesity Surgery, 2013, 23, 6, 819

    CrossRef

  39. 39
    Gunn Signe Jakobsen, Ine Blankenberg Skottheim, Rune Sandbu, Hege Christensen, Jo Røislien, Anders Åsberg, Jøran Hjelmesæth, Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin, Surgical Endoscopy, 2013, 27, 6, 2094

    CrossRef

  40. 40
    R. Hamilton, X. C. Thai, D. Ameri, M. P. Pai, Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?, Journal of Antimicrobial Chemotherapy, 2013, 68, 3, 666

    CrossRef

  41. 41
    Ilenia Pirola, Anna M. Formenti, Elena Gandossi, Francesco Mittempergher, Claudio Casella, Barbara Agosti, Carlo Cappelli, Oral Liquid l-Thyroxine (l-T4) May Be Better Absorbed Compared to l-T4 Tablets Following Bariatric Surgery, Obesity Surgery, 2013, 23, 9, 1493

    CrossRef

  42. 42
    Judith Aron-Wisnewsky, Florian Lemaitre, Karine Clément, Jean-Luc Bouillot, Christine Fernandez, Arnaud Basdevant, Jean-Michel Oppert, Marion Buyse, Pharmacokinetics of Immunomodulator Treatments After Roux-En-Y Bypass in Obese Patient, The Journal of Clinical Pharmacology, 2013, 53, 7
  43. You have free access to this content43
    James E. Mitchell, Ross Crosby, Martina de Zwaan, Scott Engel, James Roerig, Kristine Steffen, Kathryn H. Gordon, Trisha Karr, Jason Lavender, Steve Wonderlich, Possible risk factors for increased suicide following bariatric surgery, Obesity, 2013, 21, 4
  44. 44
    Astrid Müller, James E. Mitchell, Cindy Sondag, Martina de Zwaan, Psychiatric Aspects of Bariatric Surgery, Current Psychiatry Reports, 2013, 15, 10

    CrossRef

  45. 45
    M. E. Pulcini, K. K. Saules, L. M. Schuh, Roux-en-Y gastric bypass patients hospitalized for substance use disorders achieve successful weight loss despite poor psychosocial outcomes, Clinical Obesity, 2013, 3, 3-4
  46. 46
    Julie De Smet, Jan Van Bocxlaer, Koen Boussery, The Influence of Bypass Procedures and Other Anatomical Changes in the Gastrointestinal Tract on the Oral Bioavailability of Drugs, The Journal of Clinical Pharmacology, 2013, 53, 4
  47. 47
    Salvatore Benvenga, When thyroid hormone replacement is ineffective?, Current Opinion in Endocrinology & Diabetes and Obesity, 2013, 20, 5, 467

    CrossRef

  48. 48
    Ha Neul Kim, Yul Hee Cho, Young Shin Kim, Hyun Ji Chun, Su Jin Choi, Eun Oh Kim, Chul Woo Yang, A Case Report of Kidney Graft Failure after Duodenal Bypass Surgery, Korean Journal of Medicine, 2012, 83, 3, 369

    CrossRef

  49. 49
    R. S. Padwal, M. Ben-Eltriki, X. Wang, L.-A. Langkaas, A. M. Sharma, D. W. Birch, S. Karmali, D. R. Brocks, Effect of gastric bypass surgery on azithromycin oral bioavailability, Journal of Antimicrobial Chemotherapy, 2012, 67, 9, 2203

    CrossRef

  50. 50
    Julie L. Cunningham, Cory C. Merrell, Michael Sarr, Kristin J. Somers, Donald McAlpine, Michael Reese, Susanna R. Stevens, Matthew M. Clark, Investigation of Antidepressant Medication Usage after Bariatric Surgery, Obesity Surgery, 2012, 22, 4, 530

    CrossRef

  51. 51
    J. De Smet, P. Colin, P. De Paepe, J. Ruige, H. Batens, Y. Van Nieuwenhove, D. Vogelaers, S. Blot, J. Van Bocxlaer, L. M. Van Bortel, K. Boussery, Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery, Journal of Antimicrobial Chemotherapy, 2012, 67, 1, 226

    CrossRef

  52. 52
    James L. Roerig, Kristine Steffen, Cheryl Zimmerman, James E. Mitchell, Ross D. Crosby, Li Cao, Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort, Surgery for Obesity and Related Diseases, 2012, 8, 1, 62

    CrossRef

  53. 53
    Dion R Brocks, Mohamed Ben-Eltriki, Raniah Q Gabr, Raj S Padwal, The effects of gastric bypass surgery on drug absorption and pharmacokinetics, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 12, 1505

    CrossRef

  54. 54
    F. Saint-Marcoux, Absorption médicamenteuse et chirurgie bariatrique, Obésité, 2011, 6, 1, 20

    CrossRef

  55. 55
    R. S. Padwal, R. Q. Gabr, A. M. Sharma, L.-A. Langkaas, D. W. Birch, S. Karmali, D. R. Brocks, Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin, Diabetes Care, 2011, 34, 6, 1295

    CrossRef

  56. 56
    Dag Hofsø, Erlend Aasheim, Torgeir Søvik, Gunn Jakobsen, Line Johnson, Rune Sandbu, Alf Aas, Jon Kristinsson, Jøran Hjelmesæth, Oppfølging etter fedmekirurgi, Tidsskrift for Den norske legeforening, 2011, 131, 19, 1887

    CrossRef

  57. 57
    Joshua N. Nogar, Alicia B. Minns, Davut J. Savaser, Bihn T. Ly, Severe sodium channel blockade and cardiovascular collapse due to a massive Lamotrigine overdose, Clinical Toxicology, 2011, 49, 9, 854

    CrossRef

  58. 58
    J. H. Pinkney, A. B. Johnson, E. A. M. Gale, The big fat bariatric bandwagon, Diabetologia, 2010, 53, 9, 1815

    CrossRef

  59. 59
    Brian L. Erstad, Drug Dosing in the Critically Ill Obese Patient,
  60. 60
    Mea A. Weinberg, Stuart J. Froum, Management of the Medically Compromised Dental Patient,